The global pharmaceutical industry experienced a 35% decline in the number of environmental sustainability-related patent applications in Q1 2024 compared with the previous quarter. The total number of environmental sustainability-related grants dropped by 9% in Q1 2024, according to GlobalData’s Patent Analytics. GlobalData’s databook Pharma: Patents Trends Q1 2024 offers comprehensive insights into patenting trends, major players’ strategies, and geographical focus in the sector over the last three years. Buy the databook here.

Smarter leaders trust GlobalData


Premium Insights Pharma: Patents Trends Q1 2024

Buy the Databook

Premium Insights

The gold standard of business intelligence.

Find out more

Notably, the number of environmental sustainability-related patent applications in the pharmaceutical industry was 2,794 in Q1 2024, versus 4,321 in the prior quarter.

The top five companies accounted for 3% of patenting activity

Analysis of patenting activity by companies shows that Contemporary Amperex Technology filed the most environmental sustainability patents within the pharmaceutical industry in Q1 2024. The company filed 28 environmental sustainability-related patents in the quarter, compared with 34 in the previous quarter. It was followed by Johnson & Johnson with 17 environmental sustainability patent filings, F. Hoffmann-La Roche (14 filings), and Chinese Academy of Sciences (13 filings) in Q1 2024.

Patenting activity was driven by the US with a 26% share of total patent filings

The largest share of environmental sustainability related patent filings in the pharmaceutical industry in Q1 2024 was in the US with 26%, followed by China (22%) and Japan (14%). The share represented by the US was 4% higher than the 22% share it accounted for in Q4 2023.

For further understanding of GlobalData's Pharma: Patents Trends Q1 2024, buy the databook here.

This content was updated on 18 April 2024

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Patent Analytics tracks patent filings and grants from official offices around the world. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.